Outcomes in the management of obstructive unresectable stage IV colorectal cancer

European Journal of Surgical Oncology

Volumn 36, Issue 12, 2010, Pages 1187-1194

  Frago, R ^a   Kreisler, E ^a   Biondo, S ^a   Salazar, R ^b   Dominguez, J ^c   Escalante, E ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Colonic stent; Colorectal cancer; Obstruction; Outcomes; Stage IV; Survival

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; PLATINUM COMPLEX;

ADRENAL METASTASIS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLON OBSTRUCTION; COLON RESECTION; COLORECTAL CANCER; DECOMPRESSION; ELECTROCOAGULATION; FEMALE; HEART FAILURE; HUMAN; ILEUS; INCISIONAL HERNIA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PERITONEUM METASTASIS; PERITONITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND INFECTION; COLORECTAL TUMOR; COLOSTOMY; COMORBIDITY; COMPARATIVE STUDY; EMERGENCY; INTESTINE OBSTRUCTION; KAPLAN MEIER METHOD; LENGTH OF STAY; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY; PATHOLOGY; QUALITY OF LIFE; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; COLOSTOMY; COMORBIDITY; EMERGENCIES; FEMALE; FLUOROURACIL; HUMANS; INTESTINAL OBSTRUCTION; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LEUCOVORIN; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PALLIATIVE CARE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 79952113840     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.09.005     Document Type: Article

References (29)

1. Kim JS, Hur H, Min BS, et al. Oncologic outcomes of self-expanding metallic stent insertion as a bridge to surgery in the management of left-sided colon cancer obstruction: comparision with nonobstructing elective surgery. World J Surg 2009;33:1281-6.
2. Kleespies A, Füessl KE, Seeliger H, et al. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis 2009;24:1097-109.
3. Hotokezaka M, Jimi S, Hidaka H, et al. Factors influencing outcome after surgery for stage IV colorectal cancer. Surg Today 2008;38: 784-9.
4. Morise Z, Sugioka A, Fujita J, et al. Does repeated surgery improve the prognosis of colorectal liver metastases? J Gastrointest Surg 2006;10: 6-11. (Pubitemid 41820582)
5. Ratto C, Sofo L, Ippoliti M, et al. Prognostic factors in colorectal cancer. Literature review for clinical application. Dis Colon Rectum 1998; 41:1033-49. (Pubitemid 28369295)
6. Katoh H, Yamashita K, Kokuba Y, et al. Surgical resection of stage IV colorectal cancer and prognosis. World J Surg 2008;32:1130-7.
7. Biondo S, Martí-Rague J, Kreisler E, et al. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer. Am J Surg 2005;189:377-83. (Pubitemid 40488229)
8. Biondo S, Kreisler E, Millan M, et al. Differences in patient postoperative and long-term outcomes between obstructive and perforated colonic cancer. Am J Surg 2008;195:427-32. (Pubitemid 351417471)
9. American Society of Clinical Oncology.http://www.asco.org/portal/site/ ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid= 76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abstractID=32823. (ASCO, 2007).
10. Martínez-Santos C, Lobato RF, Fradejas JM, et al. Self-expandable stent before elective surgery vs. emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary ansastomosis and morbidity rates. Dis Colon Rectum 2002;45:401-6. (Pubitemid 34273624)
11. Saida Y, Sumiyama Y, Nagao J, et al. Long term prognosis of preopertative "bridge to surgery" expandable metallic stent insertion for obstructive colorrectal cancer. Comparison with emergency operation. Dis Colon Rectum 2003;46:S44-9. (Pubitemid 37266358)
12. Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysis. Surg Endosc 2004;18:421-6. (Pubitemid 38524510)
13. van Hooft JE, Fockens P, Martinelli AW, et al. Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 2008;40:184-91. (Pubitemid 351404660)
14. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715-22. Discussion 722-724.
15. SanoffHK, Sargent DJ, Campbell ME, et al. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol 2008;10(26):5721-7.
16. Jemal A, Seigel R, Ward E, et al. Cancer statistics. CA Cancer J Clin 2008;58:71-96.
17. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors (RECIST Guidelines). J Natl Cancer Inst 2000;92:205-16. (Pubitemid 30099779)
18. Biondo S, Parés S, Frago R, et al. Large bowel obstruction: predictive factors for postoperative mortality. Dis Colon Rectum 2004;47:1889-97. (Pubitemid 40064433)
19. Guidelines for the management of colo-rectal cancer. The RoyalCollege of Surgeons of Engand. The Association of Coloproctology of Great Britain and Ireland. Recommandations du ministère de la Santé britannique pour le traitement des cancers colo-rectaux. Ann Chir 1999;53:181-3.
20. Errasti J, Cermeño B, Campo E, et al. Postoperative mortality risk factors in colorectal cancer: follow up of a cohort in a specialised unit. Cir Esp 2010;8:101-7.
21. Dohmoto M. New method e endoscopic implantation of rectal stent in palliative treatment of malignant stenosis. Endosc Dig 1991;3:1507-12.
22. Jung MK, Park SY, Jeon SW, et al. Factors associated with the longterm outcome of a self-expandable colon stent used for palliation of malignant colorectal obstruction. Surg Endosc 2010;24(3):525-30.
23. Scheer MG, Sloots CE, van der Wilt GJ. Manage patients asymptomatic colorectal cancer synchronous irresectable metastases. Ann Oncol 2008;19(11):1829-35.
24. Boostrom SY, Nagorney DM, Donohue JHSarah, et al. Impact of neoadjuvant chemotherapy with FOLFOX/FOLFIRI on disease-Free and Overall survival of patients with colorectal metastases. J Gastrointest Surg 2009;13:2003-9.
25. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42. (Pubitemid 38702844)
26. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27:681-5.
27. Galizia G, Lieto E, Orditura M, et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 2008;143:352-8. (Pubitemid 351574853)
28. Gervaz P, Rubbia-Brandt L, Andres A. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: A comparison of histological response in liver metastases, primary tumors, and regional lymph nodes. Ann Surg Oncol 2010;. Apr 20.
29. Karoui M, Soprani A, Charachon A, et al. Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer. Eur J Surg Oncol 2010;36:58-64.